QA: Cue Biopharma Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001645460_2023_Cue_Biopharma_Inc.pdf

Logs

Graph

Absolute values for 0001645460, Cue Biopharma Inc.

  xvar xval
0 AssetsCurrent 77,187,474
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,499,263
3 remainder_Assets 12,596,715
4 LiabilitiesCurrent 11,548,535
5 LiabilitiesNoncurrent 14,052,342
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,168,586
9 ResearchAndDevelopmentExpense 38,578,083
10 remainder_Expenses -276,633
11 remainder_Revenues 1,245,227
12 remainder_NetIncome 214,427
13 remainder_ComprehensiveNetIncome -95,873
  yvar yval
0 Assets 91,283,452
1 Liabilities 25,600,877
2 Expenses 54,470,036
3 Revenues 1,245,227
4 StockholdersEquity 65,682,575
5 NetIncome -53,010,382
6 ComprehensiveNetIncome -53,058,318
7 BaseVar 86,454,946
8 EconomicCapitalRatio 1.03

Edgar->Model Mapping

Feature Distribution

Change over Time